This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications primarily in the United States, Canada, and internationally.View ATRI key stats
Atrion Corp - ATRI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Atrion Corp as a
Buy with a ratings score of B+.
Report Snippet: We rate ATRION CORP (ATRI) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.